Table 2 |
|||||||
|
Summary of the LCA-SEM partition using systolic and diastolic blood pressure as indicators |
|||||||
|
Entropyb |
|||||||
|
Model |
Number of subpopulations |
Co-variates in decreasing order of significansa |
With covariates |
Change |
% Normalizedd |
Correlation of indicatorse |
|
|
Excluding CRP and BNP |
|||||||
|
|
|||||||
|
Average 24 hours |
14 |
CRP HomaRes Compliance Supar VLDL Aasi WH BNP ApoE |
0.789 |
-2.3% |
66.9% |
81.8% |
71.4% |
|
Average daytime |
12 |
CRP HomaRes Compliance Supar VLDL WH BNP ApoE Aasi ApoA1 |
0.788 |
+5.3% |
61.1% |
75.0% |
83.3% |
|
Average night |
13 |
CRP HomaRes Compliance Supar VLDL BNP ApoE |
0.747 |
-9.3% |
64.1% |
79.5% |
84.6% |
|
Sitting (office BP) |
11 |
CRP Compliance VLDL Homares Age BNP BMI ApoA1 |
0.724 |
-1.0% |
50.0% |
69.1% |
81.8% |
|
Supine |
14 |
HomaRes BNP Compliance Supar VLDL CRP Age BMI ApoA1 |
0.792 |
+2.5% |
68.8% |
80.5% |
100.0% |
|
UL4c |
12 |
HomaRes CRP Supar BNP VLDL ApoA1 ApoE |
0.759 |
-5.8% |
47.0% |
65.2% |
80.6% |
|
UL2c |
14 |
HomaRes BNP Compliance Supar VLDL CRP ApoA1 Age BMI |
0.801 |
+5.8% |
68.7% |
80.8% |
28.6% |
|
|
|||||||
|
a CRP, C-reactive protein; HomaRes, insulin resistance;VLDL, very low densitity lipoprotein; Aasi, vessel stifness; WH, waist-hip ratio; BNP, B-type or brain natriuretic peptide; BMI, body mass index; Apo, apolipoprotein; Supar, soluble urokinase activator receptor. b Entropy for the full model as defined in the MPlus programme (1 - standard entropy) for the error structure. Changes signifies deviation from the model without covariates. c Ultrasound recording of systolic and diatolic blood pressure: UL4, left and rigth measurements are seperate indicators; UL2, average of left and right systelic and diastolic blood pressure, respectively, are used as indicators d Fraction of traits in all classes normalized by the LCA-SEM partition. Only the traits listed and the mode of blood pressure measurements are included in the calculation e Fraction of indicators not correalted after LCA-SEM partition |
|||||||
|
Fenger et al. BMC Genetics 2011 12:44 doi:10.1186/1471-2156-12-44 |
|||||||